The following government grants in the FederalGrants.com database contain the term National Institutes of Health in the listing.
Grants are sorted newest to oldest. Select a grant title to view the complete details, including information on who to contact and how to apply.
Grant Title | CFDA | Funding Number |
Participant Engagement and Cancer Genome Sequencing (PE-CGS): Coordinating Center (U24 Clinical Trial Not Allowed) |
93.353, 93.393, 93.396 |
RFA-CA-19-046 |
NIDDK Central Repositories Non-renewable Sample Access (X01 Clinical Trial Not Allowed) |
93.847 |
PAR-19-319 |
Participant Engagement and Cancer Genome Sequencing (PE-CGS): Research Centers (U2C Clinical Trial Optional) |
93.353, 93.393, 93.396 |
RFA-CA-19-045 |
Central Coordinating Site for the Polycystic Kidney Disease Research and Translation Core Centers (U24 Clinical Trial Not Allowed) |
93.847 |
RFA-DK-19-011 |
Polycystic Kidney Disease Research and Translation Core Centers (U54 Clinical Trial Not Allowed) |
93.847 |
RFA-DK-19-010 |
Strategic Alliances for Medications Development to Treat Substance Use Disorders (R01-Clinical Trial Optional) |
93.279 |
PAR-19-318 |
Preclinical Screening for Natural Product Drug Interactions (Clinical Trial Not Allowed, R21) |
93.213 |
RFA-AT-20-001 |
Microbiome and Aging: Impact on Health and Disease (R01 Clinical Trial Not Allowed) |
93.866 |
RFA-AG-20-030 |
Center of Excellence for Natural Product Drug interaction Research (U54, Clinical Trial Required) |
93.213 |
RFA-AT-20-002 |
Paul B. Beeson Emerging Leaders Career Development Award in Aging (K76 Independent Clinical Trial Not Allowed) |
93.866 |
RFA-AG-20-010 |
Paul B. Beeson Emerging Leaders Career Development Award in Aging (K76 Clinical Trial Required) |
93.866 |
RFA-AG-20-011 |
(Re)Building a Kidney (UC2 Clinical Trial Not Allowed) |
93.847 |
RFA-DK-19-007 |
Radiation Exposure Screening and Education Program |
93.257 |
HRSA-20-029 |
The NCI Predoctoral to Postdoctoral Fellow Transition Award (F99/K00) |
93.398 |
RFA-CA-19-057 |
Advancing Research on Alzheimer's Disease (AD) and Alzheimer's-Disease-Related Dementias (ADRD) (R41/R42 Clinical Trial Optional) |
93.866 |
PAS-19-317 |
Advancing Research on Alzheimer's Disease (AD) and Alzheimer's-Disease-Related Dementias (ADRD) (R43/R44 Clinical Trial Optional) |
93.866 |
PAS-19-316 |
NIA Program Project Applications (P01 Clinical Trial Optional) |
93.866 |
PAR-19-314 |
Comprehensive Alcohol Research Centers (P60 Clinical Trial Optional) |
93.273 |
RFA-AA-20-002 |
Specialized Alcohol Research Centers (P50 Clinical trial Optional) |
93.273 |
RFA-AA-20-001 |
Population Dynamics Centers Research Infrastructure Program FY 2020 (P2C Clinical Trial Not Allowed) |
93.865 |
RFA-HD-20-015 |
Modeling HIV Neuropathology Using Microglia from Human iPSC and Cerebral Organoids (R01 Clinical Trial Not Allowed) |
93.279 |
RFA-DA-20-023 |
Leveraging Big Data Science to Elucidate the Neural Mechanisms of Addiction and Substance Use Disorder (R21 - Clinical Trials Not Allowed) |
93.279 |
RFA-DA-20-007 |
Leveraging Big Data Science to Elucidate the Neural Mechanisms of Addiction and Substance Use Disorder (R01 - Clinical Trials Not Allowed) |
93.279 |
RFA-DA-20-006 |
Centers of Biomedical Research Excellence (COBRE) Phase 1 (P20 - Clinical Trial Optional) |
93.859 |
PAR-19-313 |
Mechanisms of Tolerance (R21/R33 - Clinical Trial Required) |
93.273 |
PAR-19-311 |
Pilot Projects Investigating Understudied G Protein-Coupled Receptors, Ion Channels, and Protein Kinases (R03 Clinical Trial Not Allowed) |
93.310 |
RFA-RM-19-011 |
Discovery of Biomarkers and Biomarker Signatures for Neurological and Neuromuscular Disorders (R61/R33 Clinical Trial Optional) |
93.853 |
PAR-19-315 |
Limited Competition: Renewal of Centers of Biomedical Research Excellence (COBRE) (Phase 2) (P20 - Clinical Trial Optional) |
93.859 |
PAR-19-312 |
Molecular Mechanisms of Blood-Brain Barrier Function and Dysfunction in Alzheimer's disease and Alzheimer's related dementias (AD/ADRD) (R01 Clinical Trial Not Allowed) |
93.853, 93.866 |
RFA-NS-20-004 |
Maximizing the Scientific Value of Existing Biospecimen Collections: Scientific Opportunities for Exploratory Research (R21 Clinical Trial Not Allowed) |
93.077 |
RFA-OD-19-021 |
Secondary Analyses of Existing Datasets of Tobacco Use and Health (R21 Clinical Trial Not Allowed) |
93.077 |
RFA-OD-19-022 |
Behavioral Science Track Award for Rapid Transition (B/Start)(R03 Clinical Trial Optional) |
93.279 |
PAR-19-310 |
Stimulating Innovations in Behavioral Intervention Research for Cancer Prevention and Control (R21 Clinical Trial Optional) |
93.393, 93.394, 93.395 |
PAR-19-309 |
Cancer Prevention Clinical Trials Network (CP-CTNet): CP-CTNet Sites (UG1 Clinical Trial Required) |
93.393, 93.399 |
RFA-CA-19-031 |
Nathan Shock Centers Coordinating Center (U24 Clinical Trial Not Allowed) |
93.866 |
RFA-AG-20-021 |
Transition to Aging Research for Predoctoral Students (F99/K00) |
93.866 |
RFA-AG-20-009 |
Nathan Shock Centers of Excellence in Basic Biology of Aging (P30 Clinical Trial Not Allowed) |
93.866 |
RFA-AG-20-020 |
Novel Technology Tools to Facilitate Research Using Next Generation Patient-derived Cancer Models (U01 Clinical Trial Not Allowed) |
93.353, 93.394, 93.395, 93.396 |
RFA-CA-19-055 |
Mechanisms of Mycobacterial-Induced Immunity in HIV-Infected and/or Uninfected Individuals to Inform Innovative Tuberculosis Vaccine Design (R01 Clinical Trial Not Allowed) |
93.855 |
PAR-19-307 |
BRAIN Initiative: Non-Invasive Neuromodulation - New Tools and Techniques for Spatiotemporal Precision (R01 Clinical Trial Optional) |
93.173, 93.213, 93.242, 93.273, 93.279, 93.286, 93.853, 93.865, 93.866, 93.867 |
RFA-MH-20-310 |
Search Results 3401-3440 of 14637 [Prev] 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 [Next] |